Pre-revenue-scale quantum encryption narrative name trading at ~250× TTM revenue after a −74% decline from 52W high and a −18.75% single-day drop on 2026-09-14 on insider selling pressure. Cash floor ~$2/share, imminent 5.44M share dilution, ~1 year cash runway. Commercial traction improving (11 contracts H1 FY26 vs 7 in full FY25) but revenue is still <$1.5M annualized against $30M+ annual burn. Base FV $6.5/share = −60% vs $16.29 spot.
Cash-anchored FV construction is the appropriate frame for a pre-revenue-scale narrative name. Base multiple implied on FY29E revenue = ~18× P/S (still generous). Cross-check hard cash floor: $2.30/share pre-dilution, $1.60/share post-dilution — the current $16.29 print embeds >85% probability of full commercial success plus strategic exit premium, which is not supported by 11 contracts / $623K H1 revenue. Sensitivity: doubling the commercialization probability (30% vs 15%) lifts FV to ~$9 — still 45% below spot. The gap between price and fundamentals-anchored FV is the option premium the market pays for "PQC theme exposure". ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Cash on balance sheet | Est. $35M cash + $18M H1 ATM raise − $15M H2 burn ≈ $38M ÷ 16.58M sh | +2.30 |
| Post-dilution adjustment | Imminent 5.44M new shares × $16 avg placement price ÷ 22.02M post-dilution → net floor $87M ÷ 22M | +3.95 |
| Commercialization option (bull path) | 15% probability × $50M FY29E revenue × 8× P/S = $400M / 22M sh × 15% | +2.72 |
| Partnership / IP strategic value | Oracle Defense + Sparkle + aerospace partner: 10% probability × $80M strategic acquisition value ÷ 22M | +0.36 |
| Cash burn to FY28 breakeven | 2 years × $25M average burn (declining) = $50M ÷ 22M sh (already partly funded by dilution above) | −2.27 |
| Legal / class-action tail | Class action settled ($7M paid); residual reserve for insurance recovery timing / any new claim | −0.55 |
| FV base case | Sum: 2.30 + 3.95 + 2.72 + 0.36 − 2.27 − 0.55 | ≈ $6.5 |
Short interest at 6.80% is moderate (5–15% band). The Sep 14 −18.75% drop is attributed to an insider selling wave amid a broader tech risk-off session; on Sep 3 the ARQQW warrants expired and were delisted, removing a technical overhang but also a source of derivative activity. Insider Form 4 monitoring recommended: no material open-market buying identified in last 12 months. Class II directors Calabria & Leaver reelected 2026-09-09 AGM with 98.1% approval — governance basic hygiene intact.
| Item | FY23 | FY24 | FY25 | FY26E | Guidance FY26 / FY27E |
|---|---|---|---|---|---|
| Revenue ($M) | 0.09 | 0.29 | 0.53 | ~1.2 | 2.5–4.0 (FY27E) |
| Number of contracts | 3 | 5 | 7 | 15+ | 20–30 (FY27E) |
| Operating loss ($M) | −54.1 | −48.3 | −35.3 | −32.0 | −25.0 (FY27E) |
| Cash burn ($M) | −45 | −38 | −30 | −28 | −22 (FY27E) |
| Cash & equivalents ($M) | ~90 | ~55 | ~35 | ~40 (post-ATM) | ~30 (post-dilution) |
| Shares outstanding (M) | 4.1 | 7.5 | 13.2 | 16.58 | 22.0+ (post-dilution) |
| Metric | H1 FY24 | H2 FY24 | H1 FY25 | H2 FY25 | H1 FY26 |
|---|---|---|---|---|---|
| Revenue ($K) | 110 | 183 | 67 | 463 | 623 |
| Contracts (active) | 3 | 4 | 4 | 7 | 11 |
| Op. loss ($M) | −26.5 | −21.8 | −19.2 | −16.1 | −15.5 |
| End-of-period cash ($M) | 68 | 55 | 42 | 35 | 40 |
| Shares (M, end period) | 6.5 | 7.5 | 10.8 | 13.2 | 16.58 |
Business model — Quantum-safe encryption & PQC migration platform
SKA-Platform + QuantumCloud ~70% of revenue FY26E 🟢 ramping Core PaaS: symmetric key delivery for quantum-safe VPNs, network encryption. Anchor partnerships: Sparkle (Italian Tier-1 telecom, 20 Equinix DCs), Oracle Defense Ecosystem (2026), Es'hailSat satellite (Sep 2026 demo). Bill model: annual license + usage. Encryption Intelligence (EI) ~15% of revenue FY26E 🟡 early commercial Automated cryptographic discovery / PQC migration compliance tool (launched Jan 2026). Larger TAM than SKA (every enterprise needs cryptographic inventory before PQC migration deadlines). Higher-margin, but competitive vs incumbents (Palo Alto, ISARA, PQShield). Services + government projects ~15% of revenue FY26E 🟡 bid activity Bespoke integration services for government/defense customers. 8 government/defense/enterprise contracts in H1 FY26. Aerospace & defense partner (likely UK primes) renewed & upsized ~90% in May 2026. Lumpy, low-visibility revenue.
Legal, regulatory and risk analysis
SWOT analysis
- +Real, differentiated technology (SKA-Platform) with satellite + terrestrial deployment history
- +Genuine commercial momentum: 11 contracts H1 FY26 vs 7 total FY25 (+57% contract count)
- +Blue-chip partnership roster (Oracle, Sparkle, aerospace & defense primes)
- +Class action legacy fully resolved (June 2026 SDNY settlement approved)
- −Revenue TTM $1.09M vs mkt cap $270M — valuation completely detached from fundamentals
- −Cash burn $30M+/year vs $35–40M cash = ~12 month runway
- −History of dilution (share count 4× since SPAC), imminent +33% dilution pending
- −Governance credibility damaged by pre-2024 disclosures (settled but publicly documented)
- →NIST/NSA PQC deadlines (2033 CNSA 2.0) force massive gov/defense migration cycle
- →Encryption Intelligence tool addresses the discovery-first phase (broader TAM than SKA alone)
- →Strategic acquisition target: Cisco/Palo Alto/Thales could see value in IP + gov relationships
- →Satellite & edge quantum-safe use cases (Es'hailSat demo Sept 2026, nLighten edge)
- !NIST-standardized PQC algorithms may prevail over Arqit's proprietary SKA approach
- !Large cybersecurity vendors (Palo Alto, Cisco) bundling PQC free with existing platforms
- !Insider selling waves (Sep 14 −19% drop) undermine share price stability
- !Prolonged risk-off in quantum narrative cohort (IONQ, RGTI, QBTS beta correlation)
Summary by assessment area
- Real technology + real customer traction, but revenue scale (~$1M) 250× below market cap
- Cash-anchored FV $6.5 = −60% vs spot $16.29; current price prices in >85% commercialization success probability
- Bear case $2 (cash floor post-dilution) is the more probable outcome (40%) vs bull case $22 (15%)
- Not a "value" setup, not a "quality" setup — pure narrative long-duration option
- Imminent 5.44M share dilution (+33%) via active F-3 shelf
- ~12 month cash runway forces further equity raises at potentially depressed prices
- Insider selling pressure (Sep 14 drop) + high beta 2.28 = amplified downside in any risk-off
- Competitive threat from NIST-standardized PQC vs Arqit's proprietary approach
- FY26 full-year results (Dec 2026): revenue actual vs $1.2M contracted, cash balance disclosure
- Any strategic contract announcement >$5M (Oracle Defense channel, gov/defense primes)
- F-3 shelf drawdown announcement (dilution event) — negative catalyst
- NIST PQC procurement milestones from gov/defense agencies (2027)
Sources: StockAnalysis.com (ARQQ overview, price history, statistics — accessed 2026-09-15); Arqit Quantum Inc. Form 6-K H1 FY2026 results (2026-05-21, GlobeNewswire); Arqit Quantum FY2025 annual results (2025-12-09); Arqit F-3 shelf registration (2026-01-23, SEC); TipRanks — $7M class action settlement (2026-01-09, approved 2026-06-01); Arqit AGM transcript (2026-09-09); Nasdaq official short interest data (1.06M shares / 6.80%); Kalkine — Arqit −19% on insider selling wave (2026-09-14); GlobeNewswire — Arqit + Es'hailSat + AIEE quantum-safe satellite demo (2026-09-01); Oracle Defense Ecosystem announcement (2026); Sparkle partnership (2025-12-03). Market data — last verified close 2026-09-14 ($16.29): ARQQ ~$16.29, market cap ~$270M, 52W: $11.52–$62.00, shares outstanding 16.58M. Short interest 6.80%. Est. cash balance $38–40M (post H1 ATM). Beta 2.28. No sell-side analyst coverage. This document is for informational purposes only and does not constitute financial or investment advice.